Development of high-throughput screens for discovery of kinesin adenosine triphosphatase modulators.
Kinesins are a group of related molecular motor proteins that have great potential as targets for antimitotic drug development. We have developed two novel assays, one end-point and one kinetic, that are useful for the discovery and optimization of kinesin modulators. Both assays measure inorganic phosphate (Pi) generated by microtubule-activated kinesin adenosine triphosphatase activity. The assays were validated using the mitotic Eg5 kinesin-specific inhibitor, monastrol. A panel of nine kinesin motor domain proteins, representing 8 of the 14 classes of kinesins, was screened. The coefficient of variation for both assays was determined to be 4-14% depending on the panel member. Using the Eg5 kinetic assay with monastrol the IC50 value was 12 microM, which agrees well with previously published results. Two other closely related mitotic kinesins (AnBimC and MKLP1) were found to have IC50 values in the millimolar range. The other panel members (kinesin heavy chain, chromokinesin KIF4A, KIF3C, CENP-E, MCAK, and KIFC3) were not significantly inhibited by millimolar levels of monastrol. It is anticipated that screening of the nine-member panel of kinesins in these assays will serve as a platform for the discovery and development of specific kinesin modulators.
Funk
C Joel
CJ
Cytoskeleton, Inc., 1830 S. Acoma, Denver, CO 80223, USA.
Davis
Ashley S
AS
Hopkins
Janet A
JA
Middleton
Kim M
KM
D000255:Adenosine Triphosphate / Q000378:metabolism*; D001681:Biological Assay / Q000379:methods*; D006801:Humans; D016547:Kinesins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007700:Kinetics; D020409:Molecular Motor Proteins / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D011743:Pyrimidines; D012997:Solvents; D013871:Thiones
D020409:Molecular Motor Proteins; D011743:Pyrimidines; D012997:Solvents; D013871:Thiones; C400223:monastrol; D000255:Adenosine Triphosphate; D016547:Kinesins